Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease
Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease have?
Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease has 29 citations in the OpenAlex counts ScholarIQ stores.
When was Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease published?
Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease has 2020 year in the ScholarIQ index.
What is the open-access status of Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease?
Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease has closed oa status in the ScholarIQ index.
What is the DOI of Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease?
The DOI for Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease is on the source record.
What is the PMID of Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease?
The PMID for Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease is on the source record.
What is the OpenAlex record for Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease?
The OpenAlex for Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease is on the source record.